| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID267 |
| PMID | 19728888 |
| Peptide Sequence | NA |
| Peptide Sequence in Publication | NA |
| Protein Name | NA |
| UniprotKB Entry Name | NA |
| Biofluid | Serum |
| M/Z | 1631.2111 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | LC-MS/MS |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | less than 0.05 |
| Software | MASCOT(v 2.0.04 for Windows) |
| Length of Peptide | NA |
| Cancer Type | "Non-small cell lung cancer (NSCLC) patients, who were treated with first-line chemotherapy" |
| Database for Peptide search | SwissProt Database (release 54.7) |
| Modification | NA |
| Number of Patients | 9 patients with partial response and 18 patients with stable disease or progresssive disease |
| Regulation/Differential Expression | Differentially expressed between NSCLC patients with a partial response versus patients with stable or progressive disease |
| Validation | Independent validation |
| Sensitivity | 1 |
| Specificity | 0.78 |
| Accuracy | 0.85 |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |